248 related articles for article (PubMed ID: 32017458)
21. The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population.
Jung CH; Hwang JY; Yu JH; Shin MS; Bae SJ; Park JY; Kim HK; Lee WJ
Clin Endocrinol (Oxf); 2012 Nov; 77(5):699-706. PubMed ID: 22211563
[TBL] [Abstract][Full Text] [Related]
22. Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
Deng J; He Y; Sun XS; Li JM; Xin MZ; Li WQ; Li ZX; Nie S; Wang C; Li YZ; Chen LP; Chen LM; Zhu SH; Li JW; Hu W; Fan YY; Guo SS; Mai HQ
Oral Oncol; 2019 Nov; 98():62-68. PubMed ID: 31541928
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of carotid plaque presence in peritoneal dialysis patients and its association with the apolipoprotein B/apolipoprotein A1 ratio.
Chen Y; Shang D; Shao J; Dai S; Ge X; Hao C; Zhu T
Nephrology (Carlton); 2020 Dec; 25(12):919-928. PubMed ID: 32691473
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma.
Li H; Li L; Huang X; Li Y; Zou T; Zhuo X; Chen Y; Liu Y; Tang Y
Strahlenther Onkol; 2019 Jun; 195(6):457-467. PubMed ID: 30689027
[TBL] [Abstract][Full Text] [Related]
26. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE.
Robinson GA; Waddington KE; Coelewij L; Peng J; Naja M; Wincup C; Radziszewska A; Peckham H; Isenberg DA; Ioannou Y; Ciurtin C; Pineda-Torra I; Jury EC
EBioMedicine; 2021 Mar; 65():103243. PubMed ID: 33640328
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional expression of radiation-induced early cortical morphological alterations and its association with radiation necrosis in patients with nasopharyngeal carcinoma.
Lin X; Guo Z; Lin S; Qiu Y
Radiother Oncol; 2023 Sep; 186():109770. PubMed ID: 37385380
[TBL] [Abstract][Full Text] [Related]
28. Serum apolipoprotein B-to-apolipoprotein A1 ratio is independently associated with disease severity in patients with acute pancreatitis.
Wu J; Wang Y; Li H; Tan W; Chen X; Ye S
Sci Rep; 2019 May; 9(1):7764. PubMed ID: 31123322
[TBL] [Abstract][Full Text] [Related]
29. A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Cai J; Cheng J; Li H; Lin WJ; Li Y; Zhuo X; Huang X; Simone CB; Aronow WS; Chow ELW; Tang Y
Radiother Oncol; 2019 Mar; 132():34-41. PubMed ID: 30825967
[TBL] [Abstract][Full Text] [Related]
30. The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes.
Mao Y; Xu Y; Lu L
Medicine (Baltimore); 2017 Jan; 96(1):e5834. PubMed ID: 28072742
[TBL] [Abstract][Full Text] [Related]
31. The apolipoprotein B/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease.
Emoto T; Sawada T; Morimoto N; Tenjin T; Wakimoto T; Ikeda F; Sato C; Terashita D; Mizoguchi T; Mizuguchi T; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
J Atheroscler Thromb; 2013; 20(7):623-9. PubMed ID: 23665841
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes.
Alsamani R; Limin Z; Jianwei W; Dan W; Yuehong S; Ziwei L; Huiwen X; Dongzhi W; Yijun S; Lingye Q; Xingquan Z; Guojun Z
J Clin Lab Anal; 2022 Jul; 36(7):e24562. PubMed ID: 35692081
[TBL] [Abstract][Full Text] [Related]
33. Utility of ApoB/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome.
Savas Erdeve S; Simsek E; Dallar Y; Biyikli Z
Indian J Pediatr; 2010 Nov; 77(11):1261-5. PubMed ID: 20924722
[TBL] [Abstract][Full Text] [Related]
34. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.
Ghorban K; Shanaki M; Mobarra N; Azad M; Asadi J; Pakzad R; Ehteram H
Hematology; 2016 Mar; 21(2):113-20. PubMed ID: 25913481
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents.
Lee YH; Choi SH; Lee KW; Kim DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):579-86. PubMed ID: 21138461
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
Liting P; Guoping L; Zhenyue C
Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
[TBL] [Abstract][Full Text] [Related]
38. Associations of serum apolipoprotein A1, B levels and their ratio with blood pressure in Chinese adults with coronary artery disease.
Dong H; Yang X; Zhang Y; Hu P; Liu Y; Liang S
Blood Press Monit; 2021 Dec; 26(6):401-406. PubMed ID: 34074807
[TBL] [Abstract][Full Text] [Related]
39. Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study.
Morrison JA; Glueck CJ; Daniels SR; Horn PS; Wang P
Metabolism; 2012 Oct; 61(10):1377-87. PubMed ID: 22512822
[TBL] [Abstract][Full Text] [Related]
40. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
